Your individual risk factors determine how your body handles this combination
Data were extracted as follows: (1) species, number exposed to drug of interest, number of controls, timing and duration of exposure, dose (drug/kg/time-interval and equivalents to maximum recommended human dosage or clinical dosage), fetal effects of maternal GLP-1 agonist or SGLT2 inhibitor exposure, (2) species, number exposed to drug of interest, number of controls, timing and duration of exposure, dose (drug/kg/time-interval and equivalents to maximum recommended human dosage or clinical dosage), the transfer of GLP-1 agonist or SGLT2 inhibitor in maternal milk and the effect of exposure during lactation on the neonate
O wyborze konkretnego postpowania zawsze decyduje lekarz, biorc pod uwag aktualne wskazania, przeciwwskazania, ryzyko dziaa niepodanych oraz cele leczenia
He, X., Gao, X., Guo, Y., & Xie, W
Adverse Reactions / Side Effects Most patients tolerate hydroxocobalamin injections well
Retinopata proliferativa
